Lauren Numedahl, RN | |
2939 W Excursion Ln, Meridian, ID 83642-5308 | |
(208) 385-7711 | |
Not Available |
Full Name | Lauren Numedahl |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 2939 W Excursion Ln, Meridian, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124741392 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 56984 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lauren Numedahl, RN 2939 W Excursion Ln, Meridian, ID 83642-5308 Ph: (208) 385-7711 | Lauren Numedahl, RN 2939 W Excursion Ln, Meridian, ID 83642-5308 Ph: (208) 385-7711 |
News Archive
Genentech, a member of the Roche Group, announced today that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint.
NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues and organs, today announced that OXY111A, its clinical stage candidate for the treatment of chronic heart failure and cancer, has been selected as one of Windover's "Top 10 Cardiovascular/Metabolic Projects to Watch."
Kidney Health Australia (KHA) has released a report that predicts that the number of people needing treatment for serious kidney disease will triple to 30,000 by 2020 and treating serious kidney disease will cost the health system $12 billion over the next decade. The report, by the George Institute for Global Health, also found the annual cost of providing dialysis treatment was just over $79,000 per patient. This was compared to just over $49,000 per person taking part in a program which delivers the treatment not in a hospital but in the patient's home.
Amputations trigger a molecular response that determines if a head or tail will be regrown in planaria, a flatworm commonly studied for its regenerative capabilities. Until now, no molecular connection between wounding and the decision to regenerate either a head or tail in planaria had been identified.
› Verified 5 days ago
Mrs. Winona Fay Latta, RN,BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5235 N Toscana Ave, Meridian, ID 83642 Phone: 208-855-0709 Fax: 208-855-0709 | |
Brian Esslinger, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1246 E Redwick Dr, Meridian, ID 83646 Phone: 208-891-9471 | |
Mark Mclaughlin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr Ste 500, Meridian, ID 83642 Phone: 208-706-7050 | |
Jennifer M Goodheart, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr, Meridian, ID 83642 Phone: 208-706-7050 | |
Mary Christine Gilbert, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr Ste 500, Meridian, ID 83642 Phone: 208-706-8050 | |
Mr. Chaunce Dolan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr Ste 500, Meridian, ID 83642 Phone: 208-706-7050 Fax: 208-706-7059 |